# FDA Inspection 1249056 - Cedars-Sinai Center for Fertility and Reproductive Medicine - September 05, 2024

Source: https://www.keypedia.com/records/fda_inspections/cedars-sinai-center-for-fertility-and-reproductive-medicine/65d82fe9-397f-4333-9df4-babf17793137
Source feed: FDA_Inspections

> FDA Inspection 1249056 for Cedars-Sinai Center for Fertility and Reproductive Medicine on September 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249056
- Company Name: Cedars-Sinai Center for Fertility and Reproductive Medicine
- Inspection Date: 2024-09-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1249056 - 2024-09-05](https://www.keypedia.com/records/fda_inspections/cedars-sinai-center-for-fertility-and-reproductive-medicine/f124348f-0905-4930-9bed-96d69b4d0485)
- [FDA Inspection 1249056 - 2024-09-05](https://www.keypedia.com/records/fda_inspections/cedars-sinai-center-for-fertility-and-reproductive-medicine/e9a456ce-6568-449f-a68f-15b516141d10)

Company: https://www.keypedia.com/companies/cedars-sinai-center-for-fertility-and-reproductive-medicine/a5fdcf16-631b-4ea3-abd3-be1826eb12fe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d